HYDERABAD: Biological E Limited's Corbevax has emerged as India's first Covid-19 vaccine to receive approval as a heterologous booster dose for those aged 18 years and above, after six months of receiving the second dose of either Covaxin or Covishield.
Drug Controller General of India (DCGI) gave the emergency use authorisation (EUA) after evaluating the clinical trial data and following deliberations with the subject experts committee (SEC).
